Aston Science

Aston Science is an artificial intelligence company in Seoul, South Korea, founded in 2018. It has raised $22.7M across 1 round.

Empowering patients with innovative cancer immunotherapy.

Headquarters
Seoul
Employees
11–50
Founded
2018
Business Model
B2B
Total Funding
$22.7M
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round for this company. The full record is or through the API.

About

Aston Sci. Inc. is a clinical-stage biopharmaceutical company founded in 2018 and headquartered in Seoul, South Korea, focused on the development of innovative medicines in oncology, immunology, and geriatrics. The company specializes in therapeutic cancer vaccines and prophylactic vaccines using innovative delivery platforms including mRNA, DNA, and peptide-based modalities. Its proprietary Th-Vac platform employs AI-driven in silico epitope prediction technology to identify and design highly selective vaccine targets, enabling the development of personalized cancer vaccines. Aston Sci.'s lead asset AST-301 is a pDNA-based HER2-targeting therapeutic cancer vaccine currently in Phase 2 clinical trials (NCT05771584) for gastric cancer, which received FDA Orphan Drug Designation. The company leads the NeoVax-K Consortium, selected for Korea's ARPA-H initiative to develop personalized cancer vaccines. Aston Sci. also collaborates with BrezezBio on antigen-specific immune tolerance for autoimmune diseases and with Certest Pharma on mRNA cancer vaccine delivery systems, expanding its platform across therapeutic and prophylactic vaccine applications.

Summary

It lists 11–50 employees. It has raised $22.7M in total across 1 round.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series CSeries C
$22.7M

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Devoted Health

Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Waltham, United States1001–5000Artificial Intelligence, Healthcare
Series G+Total funding$3.5BOct 2026
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Verily Life Sciences

Verily builds AI-native precision health platforms that help healthcare organizations harmonize d...

Dallas, United States1001–5000Artificial Intelligence, Healthcare
Corporate RoundTotal funding$3.0BMar 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Aston Science on Indexed.vc
<a href="https://indexed.vc/companies/aston-science"><img src="https://indexed.vc/api/badge/company/aston-science" alt="Aston Science on Indexed.vc" width="260" height="76" /></a>